Northwest Biotherapeutics Balance Sheet (2010-2026) | NWBO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	3.76M	3.84M	15.17M	6.96M	4.83M	9.43M	6.96M	6.19M	1.42M	6.10M	2.13M	2.48M	2.88M	2.94M	2.17M	2.78M	4.32M	4.56M	3.04M	1.79M
Short-term Investments (Quarter)
Cash & Current Investments (Quarter)	3.76M	3.84M	15.17M	6.96M	4.83M	9.43M	6.96M	6.19M	1.42M	6.10M	2.13M	2.48M	2.88M	2.94M	2.17M	2.78M	4.32M	4.56M	3.04M	1.79M
Receivables - Net (Quarter)
Receivables (Quarter)
Prepaid Assets (Quarter)	4.59M	2.47M	2.12M	2.31M	2.35M	2.34M	2.46M	3.30M	3.22M	1.75M	2.00M	2.47M	2.10M	2.25M	1.89M	1.91M	1.84M	2.33M	2.17M	4.42M
Current Assets (Quarter)	8.35M	6.31M	17.29M	9.27M	7.18M	11.76M	9.43M	9.49M	4.64M	8.45M	4.12M	4.95M	4.98M	5.19M	4.06M	4.69M	6.16M	7.20M	5.52M	6.20M
Non-Current Assets
Construction in Progress (Quarter)
Property, Plant & Equipment (Net) (Quarter)	1.31M	1.26M	15.03M	14.38M	13.75M	13.13M	13.42M	13.57M	17.29M	16.75M	17.28M	17.27M	16.96M	17.32M	16.20M	16.29M	16.68M	16.87M	17.41M	16.77M
Long-Term Investments (Quarter)
Goodwill (Quarter)	0.63M	0.63M	0.63M	0.63M	0.63M	0.63M	0.63M	0.63M	0.63M	0.63M	0.63M	0.63M	0.63M	0.63M	0.63M	0.63M	0.63M	0.63M	0.63M	0.63M
Intangibles (Quarter)	1.29M	1.29M	1.29M	1.29M	1.29M	1.29M	1.29M	1.29M	1.29M	1.29M	1.29M	1.29M	1.29M	1.29M	1.29M	1.29M	1.29M	1.29M	53.19M	52.05M
Goodwill & Intangibles (Quarter)	1.92M	1.92M	1.92M	1.92M	1.92M	1.92M	1.92M	1.92M	1.92M	1.92M	1.92M	1.92M	1.92M	1.92M	1.92M	1.92M	1.92M	1.92M	53.81M	52.67M
Other Non-Current Assets (Quarter)	1.09M	1.05M	1.04M	0.35M	0.34M	0.34M	0.34M	0.36M	0.36M	0.36M	0.36M	0.36M	0.37M	0.37M	0.36M	0.37M	0.37M	0.36M	0.36M	0.35M
Non-Current Assets (Quarter)	20.42M	21.91M	22.87M	21.39M	20.34M	19.33M	21.90M	23.38M	23.80M	23.04M	23.74M	23.62M	23.25M	24.13M	22.67M	22.82M	23.39M	23.41M	75.77M	73.85M
Assets (Quarter)	28.77M	28.22M	40.16M	30.66M	27.52M	31.10M	31.32M	32.87M	28.44M	31.49M	27.86M	28.57M	28.23M	29.32M	26.73M	27.50M	29.55M	30.61M	81.29M	80.05M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	8.16M	9.27M	6.98M	7.73M	8.37M	8.24M	10.69M	11.89M	12.11M	12.33M	10.24M	15.09M	15.14M	17.91M	16.97M	20.75M	23.66M	26.88M	30.82M	31.58M
Notes Payables (Quarter)	7.52M	282.59M	7.10M	98.62M	65.69M	73.65M	15.40M	1.45M	1.08M	1.02M	0.94M	0.91M	8.88M	7.58M	2.22M	1.04M	16.31M	13.57M	9.47M	11.65M
Payables (Quarter)	15.68M	291.86M	14.08M	106.34M	74.06M	81.89M	26.09M	13.34M	13.19M	13.35M	11.19M	16.00M	24.02M	25.49M	19.19M	21.79M	39.97M	40.45M	40.28M	43.23M
Accumulated Expenses (Quarter)
Other Accumulated Expenses (Quarter)																			8.35M	7.30M
Short term Debt (Quarter)	8.66M	8.32M	8.23M	8.31M	8.12M	8.01M	8.67M	8.45M	8.71M	8.88M	9.19M	9.10M	7.60M	9.19M	9.58M	9.48M	9.11M	9.66M	9.42M
Current Leases (Quarter)	0.25M	0.30M	0.32M	0.33M	0.33M	0.33M	0.35M	0.37M	0.39M	0.37M	0.31M	0.24M	0.17M	0.26M	0.33M	0.39M	0.45M	0.40M	0.37M	0.27M
Total Current Liabilities (Quarter)	360.71M	312.32M	133.77M	130.01M	98.16M	116.13M	126.00M	44.71M	39.92M	54.16M	45.20M	62.44M	56.17M	59.56M	68.27M	83.06M	83.92M	87.91M	91.70M	82.97M
Non-Current Liabilities
Non-Current Debt (Quarter)	12.39M	12.34M	25.16M	16.16M	16.45M	5.94M	5.99M	16.02M	15.74M	11.04M	20.31M	10.21M	20.43M	20.70M	12.40M	7.07M	9.17M	7.19M	12.33M	7.20M
Convertible Debt (Quarter)			0.30M											3.77M	15.90M	13.04M	13.77M	24.62M	5.22M	7.51M
Non-Current Deffered Revenue (Quarter)
Preferred Stock Liabilities (Quarter)						13.75M	23.06M	23.75M	25.39M	27.67M	18.72M	19.81M	18.75M	15.88M	15.51M	14.64M	13.75M	13.40M	12.71M	12.48M
Non-Current Deferred Tax Liability (Quarter)																			13.17M	12.94M
Operating Leases (Quarter)	5.51M	5.29M	5.23M	5.01M	4.57M	4.13M	4.37M	4.37M	4.37M	4.13M	4.45M	4.38M	4.36M	4.83M	4.44M	4.47M	4.62M	4.45M	4.41M	4.29M
Other Non-Current Liabilities (Quarter)	341.46M	290.92M	116.00M	107.90M	74.84M	82.58M	90.71M	10.48M	10.01M	20.15M	23.39M	26.63M	25.53M	32.52M	46.16M	47.15M	48.26M	60.81M	47.06M	38.71M
Total Non-Current Liabilities (Quarter)	17.90M	17.63M	30.38M	21.17M	21.03M	10.07M	10.36M	20.39M	24.16M	19.72M	29.72M	19.60M	29.80M	34.00M	37.43M	29.28M	32.26M	37.95M	37.16M	35.14M
Total Liabilities (Quarter)	378.61M	329.95M	164.15M	151.18M	119.19M	126.20M	136.37M	65.10M	64.09M	68.94M	74.92M	82.04M	85.97M	93.56M	105.71M	112.34M	116.18M	125.86M	128.86M	118.11M
Shareholder's Equity
Total Debt (Quarter)	21.05M	20.66M	33.39M	24.47M	24.58M	13.95M	14.66M	24.47M	24.45M	19.92M	29.50M	19.31M	28.04M	29.89M	21.97M	16.55M	18.28M	16.85M	21.75M	7.20M
Common Equity (Quarter)	-349.84M	-301.73M	-123.99M	-120.53M	-91.67M	-108.85M	-128.10M	-55.98M	-61.03M	-70.06M	-65.77M	-73.28M	-76.50M	-80.12M	-94.49M	-99.48M	-100.39M	-108.65M	-60.28M	-50.54M
Liabilities and Shareholders Equity (Quarter)	28.77M	28.22M	40.16M	30.66M	27.52M	31.10M	31.32M	32.87M	28.44M	31.49M	27.86M	28.57M	28.23M	29.32M	26.73M	27.50M	29.55M	30.61M	81.29M	80.05M
Treasury Shares (Quarter)						0.89M									0.97M	0.90M	0.84M	0.82M	12.00M	12.00M
Retained Earnings (Quarter)	-0.80M	-1325.41M	-1192.09M	1.17M	3.54M	6.31M	-1297.12M	2.40M	-1322.22M	-1340.80M	-1359.72M	2.15M	2.22M	-0.03M	-1443.50M	-1462.84M	-1.85M	-1.22M	-0.93M	-0.43M
Preferred Shares (Quarter)

Research Tools

Developers

Northwest Biotherapeutics Balance Sheet (2010-2026) | NWBO

Research Tools

Developers

Northwest Biotherapeutics Balance Sheet (2010-2026) | NWBO

Create an account

Sign In

Reset Password